메뉴 건너뛰기




Volumn 21, Issue 1, 2008, Pages 42-52

Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: An investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)

Author keywords

AZD2171; Dynamic contrast enhanced (DCE) MRI; Gadomelitol (P792, Vistarem); Vandetanib (ZD6474; Vascular endothelial growth factor (VEGF); Vascular permeability; Zactima)

Indexed keywords

BLOOD; HEMODYNAMICS; MACROMOLECULES; MECHANICAL PERMEABILITY; MEDICAL IMAGING; TUMORS;

EID: 38949156179     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1161     Document Type: Article
Times cited : (35)

References (50)
  • 1
    • 0032852528 scopus 로고    scopus 로고
    • Molecular and biological properties of vascular endothelial growth factor
    • Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999; 77: 527-543.
    • (1999) J Mol Med , vol.77 , pp. 527-543
    • Ferrara, N.1
  • 2
    • 0021978223 scopus 로고
    • Tumor angiogenesis
    • Folkman J. Tumor angiogenesis. Adv. Cancer Res. 1985; 43: 175-203.
    • (1985) Adv. Cancer Res , vol.43 , pp. 175-203
    • Folkman, J.1
  • 3
    • 0035793623 scopus 로고    scopus 로고
    • Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants
    • Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, Ferrara N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem. 2001; 276: 3222-3230.
    • (2001) J Biol Chem , vol.276 , pp. 3222-3230
    • Gille, H.1    Kowalski, J.2    Li, B.3    LeCouter, J.4    Moffat, B.5    Zioncheck, T.F.6    Pelletier, N.7    Ferrara, N.8
  • 4
    • 0033556287 scopus 로고    scopus 로고
    • A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases
    • Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Buttner M, Rziha HJ, Dehio C. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 15-1-1999; 18: 363-374.
    • EMBO J. 15-1-1999 , vol.18 , pp. 363-374
    • Meyer, M.1    Clauss, M.2    Lepple-Wienhues, A.3    Waltenberger, J.4    Augustin, H.G.5    Ziche, M.6    Lanz, C.7    Buttner, M.8    Rziha, H.J.9    Dehio, C.10
  • 5
    • 24644434383 scopus 로고    scopus 로고
    • Targeting angiogenesis with antibodies for the treatment of cancer
    • Andreasson P, Carlsson R. Targeting angiogenesis with antibodies for the treatment of cancer. IDrugs. 2005; 8: 730-733.
    • (2005) IDrugs , vol.8 , pp. 730-733
    • Andreasson, P.1    Carlsson, R.2
  • 6
    • 7444261960 scopus 로고    scopus 로고
    • Use of soluble recombinant decoy receptor vascular endothelial growth factor trap (VEGF Trap) to inhibit vascular endothelial growth factor activity
    • Konner J, Dupont J. Use of soluble recombinant decoy receptor vascular endothelial growth factor trap (VEGF Trap) to inhibit vascular endothelial growth factor activity. Clin Colorectal Cancer. 2004; 4(Suppl 2): S81-S85.
    • (2004) Clin Colorectal Cancer , vol.4 , Issue.SUPPL. 2
    • Konner, J.1    Dupont, J.2
  • 10
    • 0034655182 scopus 로고    scopus 로고
    • Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rosel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F. PTK787/ZK 222584,a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000; 60: 2178-2189.
    • Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rosel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F. PTK787/ZK 222584,a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000; 60: 2178-2189.
  • 11
    • 7444224685 scopus 로고    scopus 로고
    • Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer
    • Hurwitz H. Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer. Clin Colorectal Cancer. 2004; 4(Suppl 2): S62-S68.
    • (2004) Clin Colorectal Cancer , vol.4 , Issue.SUPPL. 2
    • Hurwitz, H.1
  • 12
    • 0033146795 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and microvascular permeability
    • Bates DO, Lodwick D, Williams B. Vascular endothelial growth factor and microvascular permeability. Microcirculation. 1999; 6: 83-96.
    • (1999) Microcirculation , vol.6 , pp. 83-96
    • Bates, D.O.1    Lodwick, D.2    Williams, B.3
  • 13
    • 8844245012 scopus 로고    scopus 로고
    • AZD2171 and ZD6474, VEGF signalling inhibitors, significantly reduce tumour vascular permeability in a human SW620 xenograft as detected by macro-molecular dynamic contrast enhanced MRI
    • Bradley D, Tessier JJ, Checkley D, Kuribayashi H, Waterton JC, Wedge SR. AZD2171 and ZD6474, VEGF signalling inhibitors, significantly reduce tumour vascular permeability in a human SW620 xenograft as detected by macro-molecular dynamic contrast enhanced MRI. Proc. Intl. Soc. Mag. Reson. Med. 2004; 121.
    • (2004) Proc. Intl. Soc. Mag. Reson. Med , pp. 121
    • Bradley, D.1    Tessier, J.J.2    Checkley, D.3    Kuribayashi, H.4    Waterton, J.C.5    Wedge, S.R.6
  • 14
    • 0346752528 scopus 로고    scopus 로고
    • Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours
    • Checkley D, Tessier JJ, Kendrew J, Waterton JC, Wedge SR. Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. Br J Cancer. 2003; 89: 1889-1895.
    • (2003) Br J Cancer , vol.89 , pp. 1889-1895
    • Checkley, D.1    Tessier, J.J.2    Kendrew, J.3    Waterton, J.C.4    Wedge, S.R.5
  • 15
    • 0037099598 scopus 로고    scopus 로고
    • PTK787/ ZK 222584,a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging
    • Drevs J, Muller-Driver R, Wittig C, Fuxius S, Esser N, Hugenschmidt H, Konerding MA, Allegrini PR, Wood J, Hennig J, Unger C, Marme D. PTK787/ ZK 222584,a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res. 2002; 62: 4015-4022.
    • (2002) Cancer Res , vol.62 , pp. 4015-4022
    • Drevs, J.1    Muller-Driver, R.2    Wittig, C.3    Fuxius, S.4    Esser, N.5    Hugenschmidt, H.6    Konerding, M.A.7    Allegrini, P.R.8    Wood, J.9    Hennig, J.10    Unger, C.11    Marme, D.12
  • 17
    • 0347615101 scopus 로고    scopus 로고
    • Morgan B, Thomas AL, Drevs J, Hennig J, Buchert M, Jivan A, Horsfield MA, Mross K, Ball HA, Lee L, Mietlowski W, Fuxuis S, Unger C, O'Byrne K, Henry A, Cherryman GR, Laurent D, Dugan M, Marme D, Steward WP. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584,an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol. 2003; 21: 3955-3964.
    • Morgan B, Thomas AL, Drevs J, Hennig J, Buchert M, Jivan A, Horsfield MA, Mross K, Ball HA, Lee L, Mietlowski W, Fuxuis S, Unger C, O'Byrne K, Henry A, Cherryman GR, Laurent D, Dugan M, Marme D, Steward WP. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584,an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol. 2003; 21: 3955-3964.
  • 18
    • 33645732568 scopus 로고    scopus 로고
    • Lee L, Sharma S, Morgan B, Allegrini P, Schnell C, Brueggen J, Cozens R, Horsfield M, Guenther C, Steward WP, Drevs J, Lebwohl D, Wood J, McSheehy PM. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemother. Pharmacol. 2006; 57: 761-771.
    • Lee L, Sharma S, Morgan B, Allegrini P, Schnell C, Brueggen J, Cozens R, Horsfield M, Guenther C, Steward WP, Drevs J, Lebwohl D, Wood J, McSheehy PM. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemother. Pharmacol. 2006; 57: 761-771.
  • 19
    • 0032853898 scopus 로고    scopus 로고
    • Key factors in the acquisition of contrast kinetic data for oncology
    • Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn. Reson. Imaging. 1999; 10: 254-259.
    • (1999) J Magn. Reson. Imaging , vol.10 , pp. 254-259
    • Evelhoch, J.L.1
  • 24
    • 38949209801 scopus 로고    scopus 로고
    • Ferretti S, Allegrini PR, McSheehy P. Correlation between effects of PTK787/ZK222584 on the interstitial fluid pressure of rat mammary tumours and their vasculature measured by contrast enhanced MRI. AACR-NCI-EORTC. 2004.
    • Ferretti S, Allegrini PR, McSheehy P. Correlation between effects of PTK787/ZK222584 on the interstitial fluid pressure of rat mammary tumours and their vasculature measured by contrast enhanced MRI. AACR-NCI-EORTC. 2004.
  • 25
  • 26
    • 0036847258 scopus 로고    scopus 로고
    • MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits
    • Ruehm SG, Christina H, Violas X, Corot C, Debatin JF. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits. Magn. Reson. Med. 2002; 48: 844-851.
    • (2002) Magn. Reson. Med , vol.48 , pp. 844-851
    • Ruehm, S.G.1    Christina, H.2    Violas, X.3    Corot, C.4    Debatin, J.F.5
  • 27
    • 10744232021 scopus 로고    scopus 로고
    • Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor Z D4190:an in vivo assessment using dynamic MR imaging and macromolecular contrast media
    • Pradel C, Siauve N, Bruneteau G, Clement O, de Bazelaire C, Frouin F, Wedge SR, Tessier JL, Robert PH, Frija G, Cuenod CA. Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor Z D4190:an in vivo assessment using dynamic MR imaging and macromolecular contrast media. Magn. Reson. Imaging. 2003; 21: 845-851.
    • (2003) Magn. Reson. Imaging , vol.21 , pp. 845-851
    • Pradel, C.1    Siauve, N.2    Bruneteau, G.3    Clement, O.4    de Bazelaire, C.5    Frouin, F.6    Wedge, S.R.7    Tessier, J.L.8    Robert, P.H.9    Frija, G.10    Cuenod, C.A.11
  • 28
    • 0036191012 scopus 로고    scopus 로고
    • Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI
    • Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson. Med. 2002; 47: 601-606.
    • (2002) Magn Reson. Med , vol.47 , pp. 601-606
    • Buckley, D.L.1
  • 29
    • 38949169166 scopus 로고    scopus 로고
    • Incorporation of Explicit Arterial Input Function for DCE-MRI Quantification: Use in Human trial of Sorafenib in Renal Cell Carcinoma
    • Rosen M, Flaherty K, Heitjan D, Schwartz B, O'Dwyer P. Incorporation of Explicit Arterial Input Function for DCE-MRI Quantification: Use in Human trial of Sorafenib in Renal Cell Carcinoma. Proc. Intl. Soc. Mag. Reson. Med. 2006; 14: 2929.
    • (2006) Proc. Intl. Soc. Mag. Reson. Med , vol.14 , pp. 2929
    • Rosen, M.1    Flaherty, K.2    Heitjan, D.3    Schwartz, B.4    O'Dwyer, P.5
  • 31
    • 0028936695 scopus 로고
    • Continuous update with random encoding (CURE): A new strategy for dynamic imaging
    • Parrish T, Hu X. Continuous update with random encoding (CURE): a new strategy for dynamic imaging. Magn. Reson. Med. 1995; 33: 326-336.
    • (1995) Magn. Reson. Med , vol.33 , pp. 326-336
    • Parrish, T.1    Hu, X.2
  • 32
    • 26944497918 scopus 로고    scopus 로고
    • Averaging keyhole pulse sequence with presaturation pulses and EXORCYCLE phase cycling for dynamic contrast-enhanced MRI
    • Kuribayashi H, Bradley DP, Checkley DR, Worthington PL, Tessier JJ. Averaging keyhole pulse sequence with presaturation pulses and EXORCYCLE phase cycling for dynamic contrast-enhanced MRI. Magn Reson. Med. Sci. 2004; 3: 207-210.
    • (2004) Magn Reson. Med. Sci , vol.3 , pp. 207-210
    • Kuribayashi, H.1    Bradley, D.P.2    Checkley, D.R.3    Worthington, P.L.4    Tessier, J.J.5
  • 33
    • 24144472335 scopus 로고    scopus 로고
    • Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters
    • Workie DW, Dardzinski BJ. Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters. Magn Reson. Med. 2005; 54: 560-568.
    • (2005) Magn Reson. Med , vol.54 , pp. 560-568
    • Workie, D.W.1    Dardzinski, B.J.2
  • 34
    • 0028395775 scopus 로고
    • Simulation of spatial and contrast distortions in keyhole imaging
    • Spraggins TA. Simulation of spatial and contrast distortions in keyhole imaging. Magn. Reson. Med. 1994; 31: 320-322.
    • (1994) Magn. Reson. Med , vol.31 , pp. 320-322
    • Spraggins, T.A.1
  • 38
    • 0024538346 scopus 로고
    • Vascular volume in B16 allografts and human melanoma xenografts estimated by means of Hoechst 33342
    • Fallowfield ME. Vascular volume in B16 allografts and human melanoma xenografts estimated by means of Hoechst 33342. J Pathol. 1989; 157: 249-252.
    • (1989) J Pathol , vol.157 , pp. 249-252
    • Fallowfield, M.E.1
  • 40
    • 3543138424 scopus 로고    scopus 로고
    • Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: Effects of transcytolemmal water exchange
    • Zhou R, Pickup S, Yankeelov TE, Springer CS Jr, Glickson JD. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Magn Reson Med. 2004; 52: 248-257.
    • (2004) Magn Reson Med , vol.52 , pp. 248-257
    • Zhou, R.1    Pickup, S.2    Yankeelov, T.E.3    Springer Jr, C.S.4    Glickson, J.D.5
  • 41
    • 85013312416 scopus 로고
    • Tumour angiogenesis: Therapeutic interventions
    • Folkman J. Tumour angiogenesis: Therapeutic interventions. N Engl J Med. 1971; 285: 1182-1186.
    • (1971) N Engl J Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 42
    • 33646371408 scopus 로고    scopus 로고
    • Burger H, den Bakker MA, Kros JM, van Tol H, de Bruin AM, Oosterhuis W, van den I, van der Harst E, de Schipper HP, Wiemer EA, Nooter K. Activating Mutations in c-KIT and PDGFRa Are Exclusively Found in Gastrointestinal Stromal Tumors and Not in Other Tumors Overexpressing these Imatinib Mesylate Target Genes. Cancer Biol. Ther. 2005; 4:1270-1274.
    • Burger H, den Bakker MA, Kros JM, van Tol H, de Bruin AM, Oosterhuis W, van den I, van der Harst E, de Schipper HP, Wiemer EA, Nooter K. Activating Mutations in c-KIT and PDGFRa Are Exclusively Found in Gastrointestinal Stromal Tumors and Not in Other Tumors Overexpressing these Imatinib Mesylate Target Genes. Cancer Biol. Ther. 2005; 4:1270-1274.
  • 44
    • 0038376002 scopus 로고    scopus 로고
    • Molecular regulation of vessel maturation
    • Jain RK. Molecular regulation of vessel maturation. Nat. Med. 2003; 9: 685-693.
    • (2003) Nat. Med , vol.9 , pp. 685-693
    • Jain, R.K.1
  • 45
    • 0029047695 scopus 로고    scopus 로고
    • Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de, Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol. 1995; 107: 233-235.
    • Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de, Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol. 1995; 107: 233-235.
  • 47
    • 2542441515 scopus 로고    scopus 로고
    • A method for interleaved acquisition of a vascular input function for dynamic contrast-enhanced MRI in experimental rat tumours
    • McIntyre DJ, Ludwig C, Pasan A, Griffiths JR. A method for interleaved acquisition of a vascular input function for dynamic contrast-enhanced MRI in experimental rat tumours. NMR Biomed. 2004; 17: 132-143.
    • (2004) NMR Biomed , vol.17 , pp. 132-143
    • McIntyre, D.J.1    Ludwig, C.2    Pasan, A.3    Griffiths, J.R.4
  • 48
    • 0033766487 scopus 로고    scopus 로고
    • Gd-DTPA relaxivity depends on macromolecular content
    • Stanisz GJ, Henkelman RM. Gd-DTPA relaxivity depends on macromolecular content. Magn. Reson. Med. 2000; 44: 665-667.
    • (2000) Magn. Reson. Med , vol.44 , pp. 665-667
    • Stanisz, G.J.1    Henkelman, R.M.2
  • 49
    • 38949156168 scopus 로고    scopus 로고
    • Quantitative perfusion measurements of liver metastisis from DCE-MRI using inversion recovery TrueFISP
    • Strecker R, Scheffler K, Hennig J. Quantitative perfusion measurements of liver metastisis from DCE-MRI using inversion recovery TrueFISP. Proc. Intl. Soc. Mag. Reson. Med. 2004; 442.
    • (2004) Proc. Intl. Soc. Mag. Reson. Med , pp. 442
    • Strecker, R.1    Scheffler, K.2    Hennig, J.3
  • 50
    • 0037406889 scopus 로고    scopus 로고
    • Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging
    • Carroll TJ, Rowley HA, Haughton VM. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology. 2003; 227: 593-600.
    • (2003) Radiology , vol.227 , pp. 593-600
    • Carroll, T.J.1    Rowley, H.A.2    Haughton, V.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.